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Cortical tremor (CT) is a form of cortical reflex myoclonus that can mimic essential tremor (ET). Clinical features that
are helpful in distinguishing CT from ET are the irregular and jerky appearance of the movements. We report two
patients with CT with coexisting orthostatic movements, either orthostatic tremor (OT) or myoclonus, who
experienced functional improvement in both cortical myoclonus and orthostatic movements when treated with
levetiracetam.
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Cortical tremor (CT) is a syndrome described in the
literature by multiple names, including familial cortical
tremor, benign adult familial myoclonic epilepsy, familial
adult myoclonic epilepsy, autosomal dominant cortical
myoclonus and epilepsy, and familial cortical myoclonic
tremor among others [1]. We will use the term CT in
this paper for consistency. Clinically small-amplitude,
irregular, jerky movements affect the distal limbs in
posture and action. The disorder can mimic essential
tremor (ET), and many patients are incorrectly diag-
nosed with ET [2]. Electrophysiologic studies however
reveal features of cortical reflex myoclonus including
cortical spikes prior to myoclonus on back-averaging,
giant somatosensory-evoked potentials (SEPs), and en-
hanced C-reflex [3].
Although tremulous movements in the legs have been
described in some case reports of CT [4,5], to our know-
ledge coincident orthostatic movements, have not been
reported in these patients. We present two patients with
CT with coexisting orthostatic movements, either or-
thostatic tremor (OT) or myoclonus, both of whom
enjoyed a favorable response to treatment of CT and
orthostatic movements with levetiracetam.* Correspondence: Pichet.Termsarasab@mountsinai.org
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Patient 1
A 61-year-old woman was referred for evaluation of
tremulous movements of her hands that had progres-
sively worsened over the past five years. Movements
could not be voluntarily suppressed and were severe
enough to cause functional disability (Additional file 1:
Video 1). In addition, she had instability when standing,
and noticed that this feeling of instability instantly dis-
appeared when she began to walk or if she held onto a
wall. There was no history of epilepsy. Examination re-
vealed frequent and moderate amplitude myoclonic jerks
affecting both hands at rest. Myoclonus was worse with
posture and action, such as when performing finger-to-
nose testing. There was a superimposed, regular, oscil-
latory action tremor of both hands with approximately
6-Hz ET-like frequency (Additional file 1: Video 1). This
tremor was also visible on Archimedes spiral (Figure 1A).
The tremor occurred in the same pattern without incon-
sistency or incongruency. When she stood, there was a
very low amplitude high frequency tremor of her legs that
was visible and palpable. Leg tremor abated immediately
when she put her hand on the wall, and disappeared when
she walked. There were no signs of parkinsonism. MRI of
the brain and routine EEG were unremarkable.
A diagnosis of CT and coincident orthostatic movements
(likely OT) was ascertained clinically. Physiologic confir-
mation was unfortunately not available. She was started on
levetiracetam with a slow titration to 2,000 mg/day, with
marked improvement of both her myoclonus, the ET-likeed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Panel A, B and C demonstrate spirals and handwriting of patient 1 in January 2013, February 2013, and May 2013,
respectively. She was on no medication in January 2013, levetiracetam 2,000 mg/day in February 2013, and levetiracetam 2,000 mg/day and
primidone 100 mg/day in May 2013. Panels A1, B1 and C1 are spirals from the left hand, and panels A2, B2 and C2, are from the right. Panels B3
and C3 are handwriting from the right hand. There is improvement of her hand spirals and handwriting over time.
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toms of OT (Additional file 2: Video 2). Primidone was
added and titrated up slowly to 100 mg/day with more
improvement in tremulous movements of her hands.
However, she could not tolerate it due to sedation, and
the dose was decreased to 50 mg/day. Clonazepam was
ineffective.
Patient 2
An 85-year-old woman presented with symptoms of un-
steadiness when standing, leading to multiple falls. She
had also noticed that on several occasions her left hand
flung out uncontrollably. On examination, low am-
plitude myoclonic jerks of the left arm occurred with
posture and action. Twenty seconds after standing up,
she developed irregular jerky movements of the left leg
which made her very unsteady. These movements dis-
appeared when she reached out for the wall or when she
began to walk, but recurred 20 seconds after she stopped
walking (Additional file 3: Video 3). There were no signs
of parkinsonism. A DAT scan obtained prior to eva-
luation by the referring neurologist was normal.
A clinical diagnosis of CT with likely coincident OT was
made; physiologic confirmation was not available. She was
treated with levetiracetam with a slow titration up to
1,500 mg/day. Significant improvement in both cortical
tremor and OT was noted, but she developed depression.
The dose was decreased to 1,000 mg/day with resolution
of depression, and symptoms of CTand OT remained well
controlled (Additional file 4: Video 4).Discussion
We present two patients whose histories and exami-
nations support the diagnosis of CT. Both patients also
had symptoms and signs of orthostatic movements, and
both conditions responded to treatment with levetirace-
tam. OT is phenomenologically distinct from cortical
myoclonus. Orthostatic myoclonus has been reported as
a differential diagnosis of OT [6,7]; we recognize that
electrophysiology would be required to distinguish these
two. The pathophysiology of orthostatic myoclonus is
still not well understood, and the link between cortical
reflex myoclonus and orthostasis myoclonus remains
unknown. In addition, the differential diagnosis in our
second patient includes late-onset asymmetric myoclo-
nus in which cortical myoclonus is an electrophysiologic
hallmark [8]. However, due to lack of electrophysiology,
we cannot confirm if the left leg movements were indeed
compatible with orthostatic tremor or myoclonus. Late-
onset asymmetric myoclonus is very rare, and the asso-
ciation between CT and this entity is unknown.
Although postural hand tremor can be seen in OT, it is
usually mild and present only when standing, unlike the
myoclonic movements of the arms in our patients. The
tremor of OT emerges after a latency with standing
and markedly improves or immediately disappears with
walking or touching a wall. OT is characterized by a 13–
18 Hz tremor of both legs that may not be visible, and is
considered to be one of the highest frequency tremors [9].
Characteristic clinical clues for the diagnosis of CT are
tremulous small amplitude movements in the distal
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not have physiologic confirmation, the appearance of the
movements and their dramatic response to levetiracetam
supports the likelihood that they were indeed myoclonic.
The distal predominance and triggering with action and
intention are other clues to a likely cortical origin of the
myoclonic jerks. Electrophysiologic testing would have
been helpful in identifying characteristic features such as
cortical spikes prior to myoclonus on back-averaging tech-
nique, giant SEPs, and enhanced C-reflex. Neither patient
had a family history of a similarly affected relative, and
neither one had a history of seizures, commonly seen in
this condition [1].
Levetiracetam is an antiepileptic medication that binds
to synaptic vesicle glycoprotein 2A (SV2A) in the brain,
which in turn inhibits presynaptic calcium channel and
neuronal activities. Levetiracetam possesses efficacy in
treating cortical myoclonus, and the response to leve-
tiracetam in our patients supports the diagnosis of CT.
Although some ET patients may experience improve-
ment with levetiracetam, the degree of improvement in
our patients was quite striking, and indeed two rando-
mized studies failed to show improvement of tremor
with the drug [10,11].
Interestingly, patient 1 also has improvement in tre-
mulous movements of her hands with primidone. This
does not necessarily reflect the diagnosis of essential
tremor. Primidone acts in the central nervous system, pos-
sibly affecting voltage-gated sodium channels, although the
exact mechanism of action is unknown. It was originally
used as an epileptic agent. Thus, we are not surprised that
her cortical tremor was improved by primidone as well.
The coincident improvement of OT in our patients de-
serves comment. The pathophysiology of OT is incom-
pletely understood. Abnormalities in central cerebello-
thalamo-cortical oscillatory networks have been proposed
[12]. The reduction of calcium currents by levetiracetam
[13] may indirectly enhance GABA in this network, which
may lead to reduction of OT. Although levetiracetam was
found to be ineffective in one double-blind crossover
study in OT [14], anecdotally some OT patients respond
to levetiracetam therapy, as did both of our patients.
Establishing a correct diagnosis of both CT and OT is
important for optimal treatment. Misinterpretation of
tremulous movements as ET may lead to treatment with
β-blockers which are typically ineffective in CT and OT
[15]. Medications that are reported to be effective in OT
include clonazepam and gabapentin. For CT, in addition
to levetiracetam, clonazepam and valproic acid may also
be effective.
Conclusion
We report the two cases of CT with co-existing ortho-
static movements, possibly OT. Levetiracetam may bean effective treatment options in these patients. Further
study in larger number of patients with CT, and electro-
physiology studies may be utilized to confirm the diag-
nosis of OT, or increase sensivity in detecting OT in CT
patients with unsteadiness.
Consent
Written informed consent was obtained from the patients
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
Additional files
Additional file 1: Video 1. Patient 1 had mild-to-moderate kinetic and
postural greater than rest “tremor” of both hands. Her “tremor” was
irregular and jerky, and in fact, it was cortical myoclonus. There was no
stimulus sensitivity to somesthetic stimuli when examining with a pin.
She felt imbalance when standing, and this feeling abated when walking.
When she stopped walking and stood still, she felt unsteady again which
was better when she touched the wall with her hand. When she wrote
or drew a spiral, there was myoclonus visible in both hands.
Additional file 2: Video 2. Video demonstrates her examination when
patient 1 was on levetiracetam 2,000 mg/day. There was improvement of
myoclonus in both hands, at rest and with action. In addition, there was
improvement of orthostatic tremor and she felt more steady when
standing. Myoclonus in both hands when writing or drawing a spiral was
also improved.
Additional file 3: Video 3. Patient 2 demonstrated mild postural and
terminal kinetic “tremor” in both hands. The “tremor” was irregular and
jerky, not typical for essential tremor. The phenomenology is indeed
myoclonus. She felt unsteady when standing, and better when walking,
touching the wall or holding the examiner’s hand or finger.
Additional file 4: Video 4. Video demonstrates the examination when
patient 2 was on levetiracetam 1,000 mg/day. There was improvement in
myoclonus of her hands, and orthostatic tremor. She felt more steady
when walking.
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